Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

COC use doesn't increase hair stress hormone levels, but hair treatments may affect results.

A simple, precise method was created for estimating Tamsulosin and Finasteride in medicine using common lab solvents, showing good precision and stability.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Finasteride reduces heart enlargement and improves heart function.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Blocking certain brain processes reduces mating behavior in female rats.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Finasteride temporarily lowers male rat fertility without affecting libido.

Finasteride causes reproductive malformations in male rats.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

The document's conclusion cannot be provided because the document is not available or cannot be read.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

BMS-470539 reduces skin fibrosis and inflammation.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Pranlukast and mirabegron may work as new diabetes drugs.

Dutasteride may become the top choice for treating hair loss.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Spironolactone plus finasteride reduces hirsutism more effectively.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.